NQMC Update Service: June 24, 2013

NQMC Update Service: June 24, 2013

NQMC Update Service: June 24, 2013

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 06/24/2013 12:49 PM EDT

June 24, 2013

New This Week

Australian Council on Healthcare Standards Radiation oncology: percentage of curative megavoltage radiotherapy courses provided, where computed tomography (CT) planning was utilised, during the 6 month time period. This updates a previously published measure summary. Radiation oncology: percentage of patients having megavoltage external beam radiotherapy, entered on prospective clinical trials, during 1 week in May or November. Radiation oncology: percentage of patients receiving megavoltage radiotherapy using multi-leaf collimators (MLCs), during the 6 month time period. This updates a previously published measure summary. Radiation oncology: percentage of patients waiting more than 14 days from the date 'ready for care' to the date of commencing radiotherapy, during 1 week in May or November. This updates a previously published measure summary. Radiation oncology: percentage of patients who had radiotherapy for breast conservation (pT1-3, any nodal staging, M0), during the 6 month time period, who had complete follow-up. This updates a previously published measure summary. Radiation oncology: percentage of patients who had radiotherapy for glottic cancer (T1-2 N0 M0), during the 6 month time period, who had complete follow-up. This updates a previously published measure summary. Radiation oncology: percentage of patients who have a letter on file to the referring doctor and general practitioner, regarding the current radiotherapy course, during 1 week in May or November. This updates a previously published measure summary. Radiation oncology: percentage of patients who have informed consent recorded in the medical record before receiving radiotherapy, during 1 week in May or November. This updates a previously published measure summary. Radiation oncology: percentage of patients who receive curative chemoradiotherapy for squamous cell carcinoma (SCC) of the cervix in the definitive or the post-operative setting, during the 6 month time period. This updates a previously published measure summary. Radiation oncology: percentage of patients with squamous cell carcinoma (SCC) of the oral cavity, oropharynx, hypopharynx and larynx who wait longer than 6 weeks from their definitive surgery to commencing their radiotherapy, during the 6 month time period. This updates a previously published measure summary.